Seguir
Miloš Miljković
Miloš Miljković
Cartesian Therapeutics
Dirección de correo verificada de cartesiantx.com - Página principal
Título
Citado por
Citado por
Año
Cytokines in the Treatment of Cancer
KC Conlon, MD Miljkovic, TA Waldmann
Journal of Interferon & Cytokine Research 39 (1), 6-21, 2019
4392019
IL-15 in the combination immunotherapy of cancer
TA Waldmann, S Dubois, MD Miljkovic, KC Conlon
Frontiers in immunology 11, 525849, 2020
1442020
IL15 by continuous intravenous infusion to adult patients with solid tumors in a phase I trial induced dramatic NK-cell subset expansion
KC Conlon, EL Potter, S Pittaluga, CCR Lee, MD Miljkovic, TA Fleisher, ...
Clinical Cancer Research 25 (16), 4945-4954, 2019
1062019
Interleukin-15 (dys) regulation of lymphoid homeostasis: Implications for therapy of autoimmunity and cancer
TA Waldmann, MD Miljkovic, KC Conlon
Journal of Experimental Medicine 217 (1), 2020
1012020
Rapid progression of adult T-cell leukemia/lymphoma as tumor-infiltrating Tregs after PD-1 blockade
DA Rauch, KC Conlon, M Janakiram, JE Brammer, JC Harding, BH Ye, ...
Blood, The Journal of the American Society of Hematology 134 (17), 1406-1414, 2019
952019
End-of-treatment and serial PET imaging in primary mediastinal B-cell lymphoma following dose-adjusted EPOCH-R: a paradigm shift in clinical decision making
C Melani, R Advani, M Roschewski, KM Walters, CC Chen, L Baratto, ...
Haematologica 103 (8), 1337, 2018
762018
Safety and clinical activity of autologous RNA chimeric antigen receptor T-cell therapy in myasthenia gravis (MG-001): a prospective, multicentre, open-label, non-randomised …
V Granit, M Benatar, M Kurtoglu, MD Miljković, N Chahin, G Sahagian, ...
The Lancet Neurology 22 (7), 578-590, 2023
432023
Potential cost implications for All US Food and drug administration oncology drug approvals in 2018
PC DeMartino, MD Miljković, V Prasad
JAMA Internal Medicine 181 (2), 162-167, 2021
382021
“Allow Natural Death” versus “Do Not Resuscitate”: What Do Patients with Advanced Cancer Choose?
MD Miljković, D Emuron, L Rhodes, J Abraham, K Miller
Journal of palliative medicine 18 (5), 457-460, 2015
322015
Short-course IL-15 given as a continuous infusion led to a massive expansion of effective NK cells: implications for combination therapy with antitumor antibodies
SP Dubois, MD Miljkovic, TA Fleisher, S Pittaluga, J Hsu-Albert, BR Bryant, ...
Journal for immunotherapy of cancer 9 (4), 2021
312021
Atrial Fibrillation and Stroke Risk in Patients With Cancer: A Primer for Oncologists
M Sorigue, MD Miljkovic
Journal of Oncology Practice 15 (12), 641-650, 2019
302019
Morphometric study of healthy jejunal and ileal mucosa in adult and aged subjects
JB Trbojević-Stanković, NM Milicevic, DP Milošević, N Despotović, ...
Histology and histopathology, 2010
262010
NF-κB–induced R-loop accumulation and DNA damage select for nucleotide excision repair deficiencies in adult T cell leukemia
Y He, N Pasupala, H Zhi, B Dorjbal, I Hussain, HM Shih, S Bhattacharyya, ...
Proceedings of the National Academy of Sciences 118 (10), e2005568118, 2021
222021
Positive predictive value of CD200 positivity in the differential diagnosis of chronic lymphocytic leukemia
M Sorigue, L Magnano, MD Miljkovic, J Nieto‐Moragas, M Santos‐Gomez, ...
Cytometry Part B: Clinical Cytometry 98 (5), 441-448, 2020
222020
Phase 1b/2 study of Vipor (Venetoclax, Ibrutinib, prednisone, Obinutuzumab, and Lenalidomide) in relapsed/refractory B-cell lymphoma: safety, efficacy and molecular analysis
C Melani, R Lakhotia, S Pittaluga, MD Miljkovic, JD Phelan, JR Muppidi, ...
Blood 136, 44-45, 2020
202020
Novel medical therapies of recurrent and metastatic gastroenteropancreatic neuroendocrine tumors
MD Miljković, M Girotra, RR Abraham, RB Erlich
Digestive diseases and sciences 57 (1), 9-18, 2012
202012
Next-generation sequencing–based monitoring of circulating tumor DNA reveals clonotypic heterogeneity in untreated PTCL
MD Miljkovic, C Melani, S Pittaluga, R Lakhotia, N Lucas, A Jacob, ...
Blood Advances 5 (20), 4198-4210, 2021
152021
Use of endoscopic ultrasound in diagnosing plasmacytoma of the pancreas
V Senadhi
JOP. Journal of the Pancreas 13 (1), 26-29, 2012
152012
Association Between US Drug Price and Measures of Efficacy for Oncology Drugs Approved by the US Food and Drug Administration From 2015 to 2020
MD Miljković, JE Tuia, T Olivier, A Haslam, V Prasad
JAMA Internal Medicine 182 (12), 1319-1320, 2022
142022
Interleukin-15 augments NK cell–mediated ADCC of alemtuzumab in patients with CD52+ T-cell malignancies
MD Miljkovic, SP Dubois, JR Müller, B Bryant, E Ma, KC Conlon, ...
Blood Advances 7 (3), 384-394, 2023
122023
El sistema no puede realizar la operación en estos momentos. Inténtalo de nuevo más tarde.
Artículos 1–20